Home » Topics » Regulatory » Patents

Patents
RSS

Endothelin antagonists described by Bristol-Myers Squibb

Oct. 29, 1997

Diester prodrugs of antiviral acyclic nucleoside disclosed by Medivir

Oct. 29, 1997

P&U describes new ergoline derivatives for CNS disorders

Oct. 27, 1997

Histamine H3 ligands prepared by James Black Foundation

Oct. 27, 1997

Researchers at Janssen/Neurocrine Biosciences develop CRF antagonists

Oct. 27, 1997

ARS discloses new 5alpha-reductase inhibitors

Oct. 27, 1997

Factor Xa inhibitors from Zeneca for use as anticoagulants/antithrombotics

Oct. 27, 1997

Improved DNA topoisomerase poisons discovered at Rutgers

Oct. 24, 1997

Anti-H. pylori cephems claimed by Fujisawa

Oct. 24, 1997

Abbott develops inhibitors of LT biosynthesis

Oct. 24, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...